US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Autonomix Medical Inc

0.3984

+0.044812.67%

Post-market: 0.39840.00000.00%18:30 EST

Volume:369.46K

Turnover:137.36K

Market Cap:2.74M

PE:-0.08

High:0.4050

Open:0.3496

Low:0.3415

Close:0.3536

52wk High:3.09

52wk Low:0.3415

Shares:6.89M

Float Shares:5.59M

Volume Ratio:1.63

T/O Rate:6.61%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.0818

EPS(LYR):-6.4594

ROE:-352.41%

ROA:-159.31%

PB:0.43

PE(LYR):-0.06

Loading ...

Overview Company News Filings

Autonomix Medical Unveils Final Clinical Data on Transvascular RF Ablation for Pancreatic Cancer Pain at SIO 2026

Autonomix Medical Faces Nasdaq Delisting Risk Over Low Share Price

Autonomix showcases PoC study clinical data at 2026 ASCO Symposium

Autonomix Medical Reports Durable Pain Relief in Pancreatic Cancer Across All Stages

Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

THOMSON REUTERS

Autonomix Medical Granted European Patent for Precision Nerve-Targeted Cardiac Therapies

Autonomix CEO Highlights IP Expansion and New Indications in Virtual Investor Segment

Autonomix Medical Showcases Long-Term Pancreatic Cancer Pain Study at 2026 ASCO Symposium

Autonomix files to sell 13.5M shares of common stock for holders

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth

Autonomix prices 4.5M shares at $1.11 in private placement

Autonomix Medical Raises $5 Million in Private Placement

Autonomix Medical Inc - Offering Price for Each Share and Series C Warrant Is $1.1107

THOMSON REUTERS

Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced at the Market Under Nasdaq Rules

THOMSON REUTERS

Nasdaq Turns Higher; NY Manufacturing Activity Surges In November

Autonomix reports results from exploratory subgroup analysis on PoC study

Autonomix Medical Reports Sustained Quality-of-Life Gains in Pancreatic Cancer Pain Study

Autonomix Medical Inc. held annual shareholder meeting

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AMIX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMIX\",,,,,undefined,":{"symbol":"AMIX","market":"US","secType":"STK","nameCN":"Autonomix Medical Inc","latestPrice":0.3984,"timestamp":1770411600000,"preClose":0.3536,"halted":0,"volume":369462,"hourTrading":{"tag":"盘后","latestPrice":0.3984,"preClose":0.3984,"latestTime":"18:30 EST","volume":8501,"amount":3376.2044,"timestamp":1770420607775,"change":0,"changeRate":0,"amplitude":0.033133},"delay":0,"changeRate":0.12669683257918538,"floatShares":5587867,"shares":6886600,"eps":-5.081781,"marketStatus":"Market Closed","change":0.0448,"latestTime":"02-06 16:00:00 EST","open":0.3496,"high":0.405,"low":0.3415,"amount":137359.0257144,"amplitude":0.179581,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.081781,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.3536,"preHourTrading":{"tag":"盘前","latestPrice":0.3502,"preClose":0.3536,"latestTime":"09:23 EST","volume":21739,"amount":7708.45070554,"timestamp":1770387812955,"change":-0.0034,"changeRate":-0.009615,"amplitude":0.027998},"postHourTrading":{"tag":"盘后","latestPrice":0.3984,"preClose":0.3984,"latestTime":"18:30 EST","volume":8501,"amount":3376.2044,"timestamp":1770420607775,"change":0,"changeRate":0,"amplitude":0.033133},"volumeRatio":1.6331660071386052},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMIX\",,,,,undefined,":{"symbol":"AMIX","floatShares":5587867,"roa":"-159.31%","roe":"-352.41%","lyrEps":-6.459374,"volumeRatio":1.6331660071386052,"shares":6886600,"dividePrice":0,"high":0.405,"amplitude":0.179581,"preClose":0.3536,"low":0.3415,"week52Low":0.3415,"pbRate":"0.43","week52High":3.09,"institutionHeld":0,"latestPrice":0.3984,"eps":-5.081781,"divideRate":0,"volume":369462,"delay":0,"ttmEps":-5.081781,"open":0.3496,"prevYearClose":0.55,"prevWeekClose":0.398,"prevMonthClose":0.398,"prevQuarterClose":0.55,"fiveDayClose":0.398,"twentyDayClose":0.4982,"sixtyDayClose":0.8565},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-10-25","symbol":"AMIX","defaultRemindTime":1729863000000,"type":"split","dateTimestamp":1729828800000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1745902800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AMIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AMIX","date":"2026-02-06","current":-0.078398,"percent":1,"low":-13.446357,"twenty":-1.512107,"median":-0.507989,"eighty":-0.302173,"high":-0.146331,"avg":-1.557897,"sd":2.471276,"marketCap":2442554},"quantilePoints":[{"date":"2024-02-02","current":-13.016254,"twenty":-12.020228,"median":-11.748584,"eighty":-11.445249,"marketCap":105524350},{"date":"2024-02-09","current":-11.884406,"twenty":-12.744611,"median":-12.008909,"eighty":-11.694255,"marketCap":96348320},{"date":"2024-02-16","current":-6.689828,"twenty":-12.495604,"median":-11.748584,"eighty":-9.339123,"marketCap":71417101},{"date":"2024-02-23","current":-7.08358,"twenty":-12.26018,"median":-11.476941,"eighty":-6.778064,"marketCap":75620597},{"date":"2024-03-01","current":-7.048515,"twenty":-11.984009,"median":-8.871831,"eighty":-6.901819,"marketCap":75246257},{"date":"2024-03-08","current":-5.374358,"twenty":-11.816495,"median":-7.647447,"eighty":-6.67112,"marketCap":57373836},{"date":"2024-03-15","current":-6.149675,"twenty":-11.757639,"median":-7.066047,"eighty":-6.204039,"marketCap":65650718},{"date":"2024-03-22","current":-5.709154,"twenty":-11.585598,"median":-6.945107,"eighty":-5.652767,"marketCap":60947944},{"date":"2024-03-28","current":-4.880974,"twenty":-11.476941,"median":-6.748784,"eighty":-5.465987,"marketCap":52106730},{"date":"2024-04-05","current":-4.889785,"twenty":-11.413557,"median":-6.607817,"eighty":-5.286254,"marketCap":52200785},{"date":"2024-04-12","current":-4.880974,"twenty":-10.76614,"median":-6.240281,"eighty":-5.025465,"marketCap":52106730},{"date":"2024-04-19","current":-5.021941,"twenty":-9.08499,"median":-5.876552,"eighty":-4.990224,"marketCap":53611617},{"date":"2024-04-26","current":-5.867918,"twenty":-7.772626,"median":-5.709154,"eighty":-5.022575,"marketCap":62642824},{"date":"2024-05-03","current":-5.744396,"twenty":-7.692486,"median":-5.744396,"eighty":-5.029941,"marketCap":61324166},{"date":"2024-05-10","current":-5.356737,"twenty":-7.527625,"median":-5.691533,"eighty":-5.029941,"marketCap":57185725},{"date":"2024-05-17","current":-4.440453,"twenty":-7.242168,"median":-5.559377,"eighty":-4.958506,"marketCap":47403956},{"date":"2024-05-24","current":-4.211382,"twenty":-7.069554,"median":-5.492065,"eighty":-4.893239,"marketCap":44958514},{"date":"2024-05-31","current":-3.735619,"twenty":-7.037907,"median":-5.4096,"eighty":-4.852781,"marketCap":39879519},{"date":"2024-06-07","current":-2.194993,"twenty":-6.985402,"median":-5.365547,"eighty":-4.757628,"marketCap":33859969},{"date":"2024-06-14","current":-1.881328,"twenty":-6.945107,"median":-5.322641,"eighty":-4.687145,"marketCap":29021367},{"date":"2024-06-21","current":-1.404888,"twenty":-6.858532,"median":-5.286254,"eighty":-4.366446,"marketCap":21671800},{"date":"2024-06-28","current":-1.233858,"twenty":-6.819267,"median":-5.285373,"eighty":-4.133851,"marketCap":19033494},{"date":"2024-07-05","current":-0.783683,"twenty":-6.748784,"median":-5.275417,"eighty":-3.96469,"marketCap":12089095},{"date":"2024-07-12","current":-0.708552,"twenty":-6.689828,"median":-5.178943,"eighty":-2.487659,"marketCap":10930125},{"date":"2024-07-15","current":-0.754975,"twenty":-6.680474,"median":-5.144494,"eighty":-2.429126,"marketCap":11646237},{"date":"2024-08-02","current":-1.258291,"twenty":-6.67112,"median":-5.110045,"eighty":-2.392543,"marketCap":19410395},{"date":"2024-08-09","current":-0.8185,"twenty":-6.614866,"median":-5.031544,"eighty":-1.746948,"marketCap":12626179},{"date":"2024-08-16","current":-0.678902,"twenty":-6.530286,"median":-4.969079,"eighty":-1.566951,"marketCap":11717848},{"date":"2024-08-23","current":-0.808829,"twenty":-6.376223,"median":-4.933837,"eighty":-1.243631,"marketCap":13960381},{"date":"2024-08-30","current":-0.766385,"twenty":-6.204039,"median":-4.889785,"eighty":-0.908657,"marketCap":13227806},{"date":"2024-09-06","current":-1.163592,"twenty":-6.121482,"median":-4.880974,"eighty":-0.908419,"marketCap":20083598},{"date":"2024-09-13","current":-1.145173,"twenty":-5.991088,"median":-4.786791,"eighty":-0.966143,"marketCap":19765688},{"date":"2024-09-20","current":-0.869424,"twenty":-5.91708,"median":-4.757628,"eighty":-0.931248,"marketCap":15006258},{"date":"2024-09-27","current":-0.782135,"twenty":-5.89597,"median":-4.695956,"eighty":-0.867778,"marketCap":13499642},{"date":"2024-10-04","current":-0.775461,"twenty":-5.864359,"median":-4.440453,"eighty":-0.840755,"marketCap":13384458},{"date":"2024-10-11","current":-0.783603,"twenty":-5.828976,"median":-4.162925,"eighty":-0.815034,"marketCap":13524983},{"date":"2024-10-18","current":-0.767453,"twenty":-5.744396,"median":-4.017553,"eighty":-0.801154,"marketCap":13246236},{"date":"2024-10-25","current":-0.660676,"twenty":-5.737348,"median":-3.682756,"eighty":-0.798098,"marketCap":11403275},{"date":"2024-10-31","current":-0.683366,"twenty":-5.709154,"median":-2.900189,"eighty":-0.790143,"marketCap":11794903},{"date":"2024-11-08","current":-0.788474,"twenty":-5.691533,"median":-2.37791,"eighty":-0.788808,"marketCap":13609060},{"date":"2024-11-15","current":-0.785853,"twenty":-5.608715,"median":-1.832463,"eighty":-0.788808,"marketCap":11023166},{"date":"2024-11-22","current":-1.110505,"twenty":-5.568187,"median":-1.722515,"eighty":-0.788808,"marketCap":15577054},{"date":"2024-11-29","current":-0.404119,"twenty":-5.554091,"median":-1.649216,"eighty":-0.787206,"marketCap":5668573},{"date":"2024-12-06","current":-0.296518,"twenty":-5.550567,"median":-1.386563,"eighty":-0.783683,"marketCap":4159257},{"date":"2024-12-13","current":-0.258735,"twenty":-5.503765,"median":-1.233858,"eighty":-0.781801,"marketCap":3629269},{"date":"2024-12-20","current":-0.246414,"twenty":-5.426093,"median":-1.173656,"eighty":-0.779652,"marketCap":3456447},{"date":"2024-12-27","current":-0.286661,"twenty":-5.4096,"median":-1.162724,"eighty":-0.772476,"marketCap":4021000},{"date":"2025-01-03","current":-0.276805,"twenty":-5.402552,"median":-1.152867,"eighty":-0.766812,"marketCap":3882742},{"date":"2025-01-10","current":-0.234915,"twenty":-5.388455,"median":-1.126704,"eighty":-0.721272,"marketCap":3295146},{"date":"2025-01-17","current":-0.234915,"twenty":-5.370834,"median":-1.094455,"eighty":-0.690174,"marketCap":3295146},{"date":"2025-01-24","current":-0.245592,"twenty":-5.356737,"median":-1.065091,"eighty":-0.664926,"marketCap":3444925},{"date":"2025-01-31","current":-0.250521,"twenty":-5.323786,"median":-0.993874,"eighty":-0.650158,"marketCap":3514054},{"date":"2025-02-07","current":-0.223415,"twenty":-5.321496,"median":-0.95965,"eighty":-0.514527,"marketCap":3133845},{"date":"2025-02-14","current":-0.234093,"twenty":-5.286254,"median":-0.921104,"eighty":-0.367978,"marketCap":3283624},{"date":"2025-02-21","current":-0.529577,"twenty":-5.286254,"median":-0.884394,"eighty":-0.396891,"marketCap":7216540},{"date":"2025-02-28","current":-0.51331,"twenty":-5.284844,"median":-0.870433,"eighty":-0.404119,"marketCap":6994871},{"date":"2025-03-07","current":-0.451857,"twenty":-5.282659,"median":-0.864124,"eighty":-0.424958,"marketCap":6157457},{"date":"2025-03-14","current":-0.370523,"twenty":-5.271347,"median":-0.855149,"eighty":-0.404119,"marketCap":5049115},{"date":"2025-03-21","current":-0.395827,"twenty":-5.261585,"median":-0.840795,"eighty":-0.370014,"marketCap":5393932},{"date":"2025-03-28","current":-0.345219,"twenty":-5.195119,"median":-0.827514,"eighty":-0.359722,"marketCap":4704297},{"date":"2025-04-04","current":-0.301841,"twenty":-5.123825,"median":-0.816667,"eighty":-0.342327,"marketCap":4113181},{"date":"2025-04-11","current":-0.296418,"twenty":-5.095949,"median":-0.808829,"eighty":-0.326745,"marketCap":4039292},{"date":"2025-04-17","current":-0.319915,"twenty":-5.060707,"median":-0.801955,"eighty":-0.319099,"marketCap":4359479},{"date":"2025-04-25","current":-0.35534,"twenty":-5.029941,"median":-0.800887,"eighty":-0.320999,"marketCap":4842224},{"date":"2025-05-02","current":-0.413901,"twenty":-5.022575,"median":-0.797617,"eighty":-0.323356,"marketCap":5640231},{"date":"2025-05-09","current":-0.307263,"twenty":-4.990224,"median":-0.789475,"eighty":-0.323356,"marketCap":4187071},{"date":"2025-05-16","current":-0.343411,"twenty":-4.958506,"median":-0.788474,"eighty":-0.320999,"marketCap":4679667},{"date":"2025-05-23","current":-0.332567,"twenty":-4.951458,"median":-0.785996,"eighty":-0.321722,"marketCap":4531888},{"date":"2025-05-30","current":-0.301841,"twenty":-4.937361,"median":-0.783988,"eighty":-0.317967,"marketCap":4113181},{"date":"2025-06-06","current":-0.336289,"twenty":-4.909097,"median":-0.783603,"eighty":-0.31883,"marketCap":3837062},{"date":"2025-06-13","current":-0.333852,"twenty":-4.894965,"median":-0.781726,"eighty":-0.320638,"marketCap":3809257},{"date":"2025-06-20","current":-0.292426,"twenty":-4.888023,"median":-0.781,"eighty":-0.31701,"marketCap":3336576},{"date":"2025-06-27","current":-0.30461,"twenty":-4.880974,"median":-0.775594,"eighty":-0.314854,"marketCap":3475600},{"date":"2025-07-03","current":-0.346037,"twenty":-4.880974,"median":-0.774126,"eighty":-0.3163,"marketCap":3948281},{"date":"2025-07-11","current":-0.367969,"twenty":-4.845733,"median":-0.767586,"eighty":-0.3163,"marketCap":4198524},{"date":"2025-07-18","current":-0.402085,"twenty":-4.801681,"median":-0.754975,"eighty":-0.316794,"marketCap":4587792},{"date":"2025-07-25","current":-0.350911,"twenty":-4.771901,"median":-0.713978,"eighty":-0.317874,"marketCap":4003891},{"date":"2025-08-01","current":-0.350911,"twenty":-4.757628,"median":-0.696046,"eighty":-0.317874,"marketCap":4003891},{"date":"2025-08-08","current":-0.302173,"twenty":-4.757628,"median":-0.681134,"eighty":-0.316794,"marketCap":3447795},{"date":"2025-08-15","current":-0.260785,"twenty":-4.740008,"median":-0.660908,"eighty":-0.314493,"marketCap":3141942},{"date":"2025-08-22","current":-0.337222,"twenty":-4.704766,"median":-0.65435,"eighty":-0.314493,"marketCap":4062851},{"date":"2025-08-29","current":-0.515256,"twenty":-4.687145,"median":-0.552729,"eighty":-0.314493,"marketCap":6207806},{"date":"2025-09-05","current":-0.503546,"twenty":-4.517985,"median":-0.552729,"eighty":-0.315939,"marketCap":6066719},{"date":"2025-09-12","current":-0.543361,"twenty":-4.447501,"median":-0.545703,"eighty":-0.3163,"marketCap":6546413},{"date":"2025-09-19","current":-0.517853,"twenty":-4.41226,"median":-0.548045,"eighty":-0.316695,"marketCap":6239091},{"date":"2025-09-26","current":-0.507989,"twenty":-4.250148,"median":-0.545403,"eighty":-0.317658,"marketCap":6120251},{"date":"2025-10-03","current":-0.577036,"twenty":-4.133851,"median":-0.543361,"eighty":-0.31806,"marketCap":6952130},{"date":"2025-10-10","current":-0.621423,"twenty":-4.079226,"median":-0.547745,"eighty":-0.319006,"marketCap":7486909},{"date":"2025-10-17","current":-0.547444,"twenty":-4.028125,"median":-0.547444,"eighty":-0.319231,"marketCap":6595611},{"date":"2025-10-24","current":-0.552376,"twenty":-3.975263,"median":-0.547745,"eighty":-0.319778,"marketCap":6655031},{"date":"2025-10-31","current":-0.507989,"twenty":-3.781433,"median":-0.547444,"eighty":-0.321317,"marketCap":6120251},{"date":"2025-11-07","current":-0.424343,"twenty":-3.651039,"median":-0.547444,"eighty":-0.321711,"marketCap":5112489},{"date":"2025-11-14","current":-0.360179,"twenty":-3.376154,"median":-0.547444,"eighty":-0.321722,"marketCap":4339436},{"date":"2025-11-21","current":-0.411623,"twenty":-2.652671,"median":-0.543361,"eighty":-0.321722,"marketCap":6870808},{"date":"2025-11-28","current":-0.441452,"twenty":-2.443759,"median":-0.538098,"eighty":-0.322807,"marketCap":7368713},{"date":"2025-12-05","current":-0.358937,"twenty":-2.392543,"median":-0.532649,"eighty":-0.324079,"marketCap":5991383},{"date":"2025-12-12","current":-0.318981,"twenty":-2.26816,"median":-0.5271,"eighty":-0.322807,"marketCap":5324438},{"date":"2025-12-19","current":-0.261045,"twenty":-2.006794,"median":-0.522785,"eighty":-0.319641,"marketCap":4357363},{"date":"2025-12-26","current":-0.247554,"twenty":-1.842236,"median":-0.522785,"eighty":-0.318457,"marketCap":4132172},{"date":"2026-01-02","current":-0.227607,"twenty":-1.771381,"median":-0.519933,"eighty":-0.316399,"marketCap":3799222},{"date":"2026-01-09","current":-0.206171,"twenty":-1.722515,"median":-0.517853,"eighty":-0.314493,"marketCap":3441405},{"date":"2026-01-16","current":-0.215317,"twenty":-1.712139,"median":-0.515826,"eighty":-0.308968,"marketCap":3594064},{"date":"2026-01-23","current":-0.195039,"twenty":-1.670634,"median":-0.515117,"eighty":-0.307047,"marketCap":3255588},{"date":"2026-01-30","current":-0.165533,"twenty":-1.649216,"median":-0.51331,"eighty":-0.30461,"marketCap":2763071},{"date":"2026-02-06","current":-0.146331,"twenty":-1.512107,"median":-0.507989,"eighty":-0.302173,"marketCap":2442554}],"updateTime":1770459255816},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AMIX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606110327","title":"Autonomix Medical Unveils Final Clinical Data on Transvascular RF Ablation for Pancreatic Cancer Pain at SIO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2606110327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606110327?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:30","pubTimestamp":1769607034,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. has announced that final clinical data evaluating its transvascular radiofrequency  ablation approach for pain mitigation in patients with pancreatic adenocarcinoma will be presented at the Society of Interventional Oncology  2026 Annual Scientific Meeting, scheduled to take place February 4-8, 2026, in Savannah, Georgia. The presentation, titled \"Pain Mitigation in Pancreatic Adenocarcinoma: A Final Analysis of Neurolysis via Transvascular Radiofrequency  Ablation,\" will be delivered as an ePoster by Clarke Wilkirson, PhD, on February 6, 2026, during the Science and Sips Reception. The results have not yet been presented and will be shared at the upcoming meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL4DWKQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","SG9999014021.USD","BK4112","BK4082","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD","SG9999014005.SGD","AMIX","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","NDAQ","SG9999014013.SGD","LU2095319765.USD","BK4588"],"gpt_icon":0},{"id":"2603199306","title":"Autonomix Medical Faces Nasdaq Delisting Risk Over Low Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2603199306","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603199306?lang=en_us&edition=fundamental","pubTime":"2026-01-16 20:31","pubTimestamp":1768566664,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. has received a deficiency letter from the Nasdaq Stock Market after its common stock closed below the minimum $1.00 per share requirement for 30 consecutive business days, violating Nasdaq Listing Rule 5550. The company has until July 13, 2026, to regain compliance or risk delisting from the Nasdaq Capital Market. Potential remedies to meet the listing requirement, such as a reverse stock split, are being considered, but there is no assurance of regaining compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchang","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDL6lcBjh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMIX","BK4082"],"gpt_icon":0},{"id":"2602371368","title":"Autonomix showcases PoC study clinical data at 2026 ASCO Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2602371368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602371368?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:51","pubTimestamp":1767966686,"startTime":"0","endTime":"0","summary":"Autonomix (AMIX) Medical announced new subgroup clinical data from its PoC study presented at the 2026 ASCO Gastrointestinal Cancers Symposium demo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autonomix-showcases-poc-study-clinical-data-at-2026-asco-symposium-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autonomix-showcases-poc-study-clinical-data-at-2026-asco-symposium-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2602379103","title":"Autonomix Medical Reports Durable Pain Relief in Pancreatic Cancer Across All Stages","url":"https://stock-news.laohu8.com/highlight/detail?id=2602379103","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602379103?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:45","pubTimestamp":1767966311,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. announced new subgroup clinical data from its proof-of-concept study, which was presented at the 2026 ASCO Gastrointestinal  Cancers Symposium. The data demonstrated rapid, durable, and clinically meaningful pain relief in pancreatic cancer patients across all disease stages, from Stage 2 through Stage 4, including those with limited treatment options. The findings were shared during Poster Session B under the title \"Pain mitigation in pancreatic adenocarcinoma: A long-term analysis of denervation via transvascular RF energy-based ablation\" by Dr. Robert S. Schwartz, Chief Medical Officer of Autonomix Medical. The dataset included patients with severe pancreatic cancer-related pain, and the subgroup analysis expanded upon previously reported results from the company’s ongoing clinical evaluation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL8nCJH3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014005.SGD","LU0314104364.USD","NDAQ","SG9999014021.USD","AMIX","IE00BGHQF748.EUR","BK4588","SG9999014013.SGD","LU2210150020.SGD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","BK4585","LU2095319765.USD","SG9999014039.USD","BK4082"],"gpt_icon":0},{"id":"2595704797","title":"Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology","url":"https://stock-news.laohu8.com/highlight/detail?id=2595704797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595704797?lang=en_us&edition=fundamental","pubTime":"2025-12-30 21:30","pubTimestamp":1767101453,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00FG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2595179709","title":"Autonomix Medical Granted European Patent for Precision Nerve-Targeted Cardiac Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2595179709","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595179709?lang=en_us&edition=fundamental","pubTime":"2025-12-30 21:30","pubTimestamp":1767101412,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. has been granted European Patent No. EP4230133, titled \"Controlled and Precise Treatment of Cardiac Tissues.\" The patent covers systems, devices, and methods for sensing autonomic and cardiac signals, mapping targets, and delivering therapy with closed-loop feedback to precisely treat cardiac tissues through feedback-driven neuromodulation, denervation, and ablation. This new patent strengthens the company’s intellectual property portfolio and supports its strategy to provide precision nerve-targeted therapies in high-growth areas such as cardiology and resistant hypertension.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDLtLqbX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014005.SGD","SG9999014021.USD","IE00B64PRP62.GBP","BK4588","NDAQ","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014013.SGD","BK4585","BK4082","LU2210149790.SGD","AMIX","SG9999014039.USD","BK4112"],"gpt_icon":0},{"id":"2593941336","title":"Autonomix CEO Highlights IP Expansion and New Indications in Virtual Investor Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2593941336","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593941336?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:45","pubTimestamp":1766497507,"startTime":"0","endTime":"0","summary":"Autonomix Medical, Inc. , a medical device company focused on advancing precision nerve-targeted treatments, recently participated in a Virtual Investor CEO Connect segment. During the event, CEO Brad Hauser highlighted the company's commitment to expanding its intellectual property portfolio and exploring multi-indication opportunities for its platform technology, which includes a catheter-based microchip sensing array aimed at improving the diagnosis and treatment of diseases involving the nervous system. Hauser discussed the company's initial focus on pain management, particularly in pancreatic cancer, and emphasized potential future applications in cardiovascular, pulmonary, and interventional pain management. The Virtual Investor CEO Connect segment is now available here.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for information","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL7dj0s3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014013.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014005.SGD","BK4588","IE00B64PRP62.GBP","BK4082","LU2210150020.SGD","AMIX","LU2210149790.SGD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","IE00BKPKM429.USD","BK4585","BK4112"],"gpt_icon":0},{"id":"2592909572","title":"Autonomix Medical Showcases Long-Term Pancreatic Cancer Pain Study at 2026 ASCO Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2592909572","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592909572?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:30","pubTimestamp":1766064628,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. has announced that its abstract titled \"Pain mitigation in pancreatic adenocarcinoma: A long-term analysis of denervation via transvascular RF energy-based ablation\" has been accepted for poster presentation at the 2026 American Society of Clinical Oncology  Gastrointestinal Cancers Symposium. The presentation, to be delivered by Chief Medical Officer Robert S. Schwartz, MD, will take place on January 9, 2026, in San Francisco, California. The results of the study will be presented at the symposium and have not yet been disclosed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire  on December 18, 2025, and is sol","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL9gH76V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","SG9999014021.USD","BK4112","BK4082","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD","SG9999014005.SGD","AMIX","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","NDAQ","SG9999014013.SGD","LU2095319765.USD","BK4588"],"gpt_icon":0},{"id":"2586110293","title":"Autonomix files to sell 13.5M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2586110293","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586110293?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:10","pubTimestamp":1764195011,"startTime":"0","endTime":"0","summary":"This offering relates to the resale by the selling stockholder of up to an aggregate of 9,003,332 shares of Autonomix (AMIX) common stock issuable ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autonomix-files-to-sell-13-5m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autonomix-files-to-sell-13-5m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2586250635","title":"Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250635","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586250635?lang=en_us&edition=fundamental","pubTime":"2025-11-26 21:45","pubTimestamp":1764164700,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, TX, Nov.  26, 2025  (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/26/3195151/0/en/Autonomix-Medical-Inc-NASDAQ-AMIX-Announces-Release-of-the-Next-CEO-Corner-Segment-Highlighting-Continued-Execution-and-Strategic-Growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","USAW.SI","NVIW.SI","NQmain","TSYW.SI","AMIX",".IXIC","QLD","SQQQ","BK4082","QID","USJW.SI","TQQQ","MNQmain"],"gpt_icon":1},{"id":"2584959303","title":"Autonomix prices 4.5M shares at $1.11 in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2584959303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584959303?lang=en_us&edition=fundamental","pubTime":"2025-11-18 23:00","pubTimestamp":1763478039,"startTime":"0","endTime":"0","summary":"Autonomix (AMIX) Medical entered into a securities purchase agreement with a single institutional investor to purchase 4,501,666 shares of common s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autonomix-prices-4-5m-shares-at-1-11-in-private-placement-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autonomix-prices-4-5m-shares-at-1-11-in-private-placement-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2584958800","title":"Autonomix Medical Raises $5 Million in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2584958800","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584958800?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:34","pubTimestamp":1763472851,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. has announced a private placement with a single institutional investor, raising approximately $5.0 million through the sale of 4,501,666 shares of common stock  and unregistered Series C warrants to purchase up to 9,003,332 shares of common stock. The combined offering price is $1.1107 per share and accompanying warrant, with each Series C warrant carrying an exercise price of $0.8607 per share, exercisable immediately and expiring five and a half years from issuance. The securities are being sold under Section 4 and/or Regulation D and are not registered under the Securities Act. Autonomix has agreed to file a registration statement to register the resale of the securities. Maxim Group LLC is serving as the sole placement agent for the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational pu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL6Vzdy3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMIX","BK4082"],"gpt_icon":0},{"id":"2584930710","title":"Autonomix Medical Inc - Offering Price for Each Share and Series C Warrant Is $1.1107","url":"https://stock-news.laohu8.com/highlight/detail?id=2584930710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584930710?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:30","pubTimestamp":1763472600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUA1DRHLL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMIX","BK4082"],"gpt_icon":0},{"id":"2584493044","title":"Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced at the Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2584493044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584493044?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:30","pubTimestamp":1763472600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUA1DRHLL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2584706678","title":"Nasdaq Turns Higher; NY Manufacturing Activity Surges In November","url":"https://stock-news.laohu8.com/highlight/detail?id=2584706678","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584706678?lang=en_us&edition=fundamental","pubTime":"2025-11-18 01:31","pubTimestamp":1763400668,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/11/48904871/nasdaq-turns-higher-ny-manufacturing-activity-surges-in-november","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","IE00B12V2V27.USD","BK4168","IE00BYTNYN87.SGD","PACS","USAW.SI","LU0455707207.USD","NQmain","LU0359201612.USD","SQQQ","PSQ","USJW.SI","LU2247934214.USD",".IXIC","BK4503","LU0359202008.SGD","BK4588","QID","LU1023057109.AUD","TQQQ","YMM","BK4022","BK4526","LU0456842615.SGD","NVIW.SI","MNQmain","LU0502904849.HKD","BK4548","SGML","BK4140","TSYW.SI","BK4232","LU0572944931.SGD","BK4183","LU2242644610.SGD","BK4185","BK4539","BK4585","AMIX","YSG","BK4082","SG9999011746.SGD","LU0359201885.HKD","IE00BYQNZ168.SGD","TAIT","LU0327786744.USD","QLD"],"gpt_icon":1},{"id":"2584626383","title":"Autonomix reports results from exploratory subgroup analysis on PoC study","url":"https://stock-news.laohu8.com/highlight/detail?id=2584626383","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584626383?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:15","pubTimestamp":1763385320,"startTime":"0","endTime":"0","summary":"Autonomix (AMIX) Medical announced results from a post-hoc exploratory subgroup analysis of its previously reported first-in-human proof-of-concept...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autonomix-reports-results-from-exploratory-subgroup-analysis-on-poc-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autonomix-reports-results-from-exploratory-subgroup-analysis-on-poc-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2584625258","title":"Autonomix Medical Reports Sustained Quality-of-Life Gains in Pancreatic Cancer Pain Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2584625258","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584625258?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:13","pubTimestamp":1763385207,"startTime":"0","endTime":"0","summary":"Autonomix Medical, Inc.  has announced results from a post-hoc exploratory subgroup analysis of its first-in-human proof-of-concept study  evaluating a targeted ablation therapy for severe pancreatic cancer pain. The study examined the safety and effectiveness of delivering transvascular energy to ablate problematic nerves. The subgroup analysis assessed patient-reported quality-of-life, symptoms, and functional outcomes using the EORTC QLQ-C30 scale across various patient groups, including those with different tumor stages and metastatic status. Results indicated improvements in symptom scores, functionality, and global quality of life at both 4-6 weeks and 3 months post-treatment, with all 3-month results exceeding the EORTC threshold for clinically meaningful change. These findings, along with previously reported pain reduction and opioid-free outcomes, will inform the design of Autonomix's planned U.S.-based multicenter clinical trial, scheduled to begin in 2026.Disclaimer: This ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL2ZcZlW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2580226038","title":"Autonomix Medical Inc. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2580226038","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580226038?lang=en_us&edition=fundamental","pubTime":"2025-11-04 06:01","pubTimestamp":1762207261,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. held its annual meeting of stockholders on October 30, 2025. Stockholders elected five nominees to the Board of Directors. The appointment of Forvis Mazars, LLP as the independent registered public accounting firm for the year ending March 31, 2026, was ratified. An amendment to the certificate of incorporation granting the Board authority to implement a reverse stock split at a ratio between 1-for-2 and 1-for-25 was approved. The amended and restated 2023 Equity Incentive Plan was approved. Approval was also given for the issuance of more than 20% of the company's common stock pursuant to a purchase agreement with Lincoln Park Capital Fund, LLC.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical In","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL2cQpjL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMIX","BK4082"],"gpt_icon":0},{"id":"2577351142","title":"Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2577351142","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577351142?lang=en_us&edition=fundamental","pubTime":"2025-10-24 21:00","pubTimestamp":1761310800,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, TX, Oct.  24, 2025  (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.(NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted tr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/24/3172838/0/en/Autonomix-Medical-Inc-Featured-in-Two-Innovation-in-Interventional-Cardiology-Podium-Presentations-at-the-Transcatheter-Cardiovascular-Therapeutics-TCT-Annual-Scientific-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMIX","LENZ","CSII","BK4007","CRF","BK4539","BK4139","BK4082"],"gpt_icon":0},{"id":"2575747164","title":"Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2575747164","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575747164?lang=en_us&edition=fundamental","pubTime":"2025-10-16 21:15","pubTimestamp":1760620500,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, TX, Oct.  16, 2025  (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.(NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/16/3167993/0/en/Autonomix-Medical-Inc-to-Highlight-Innovative-Nerve-Sensing-and-Ablation-Platform-at-the-2025-Maxim-Growth-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4082","AMIX","SMMF"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}